NICE gains wider public health role
December 7, 2011Sales and Marketing NICE
NICE is to gain new powers to advise local authorities in England and Wales about public health.From 2013 responsibility for public health will …
No cancer link with Lantus, says Sanofi
December 7, 2011Sales and Marketing Cancer, Lantus, Sanofi, diabetes, insulin, safety
Sanofi has presented a new meta-analysis which suggests its insulin blockbuster Lantus does not raise the risk of cancer. A …
NICE recommends two Novartis cancer treatments
December 6, 2011Sales and Marketing Glivec, Novartis, Sprycel, Tasigna
Two of Novartis’ cancer drugs have been recommended by NICE for the first line treatment of chronic myeloid leukaemia (CML) …
GlaxoSmithKline moves closer to green power goals
December 6, 2011Manufacturing and Production GSK, manufacturing
GlaxoSmithKline took a step closer to becoming a generator of electricity in a bid to offset the high energy demands …
Pharma manufacturing news in brief
December 6, 2011Manufacturing and Production GSK, Hospira, PharmaS, UPS, Uquifa, Vivimed
India’s Vivimed buys Spanish API maker, Hospira tries to spend its way out of manufacturing woes, plus updates from PharmaS, …
SciGen sells Israeli vaccines plant to FDS
December 6, 2011Manufacturing and Production FDS, SciGen
UK drugmaker FDS Pharma has bought a manufacturing facility in Israel operated by Singapore biopharmaceutical concern SciGen. FDS Pharma has …
Actavis buys packager to boost manufacturing efficiencies
December 6, 2011Manufacturing and Production Actavis, pharmapack
Generic drugmaker Actavis has acquired Netherlands-based company PharmaPack International in a bid to cut its lead times for packaging and …
Cervarix was the ‘wrong decision’ for the UK
December 6, 2011Sales and Marketing
The UK government’s choice to use GlaxoSmithKline’s Cervarix for its HPV vaccination programme was the ‘wrong decision’, according to a …
Big pharma: big rewards come from big risks
December 5, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, R&D productivity
John LaMattina joined Pfizer in 1977 after having completed his PhD in organic chemistry, and moved up through the ranks …
AstraZeneca to freely share drug compounds with UK groups
December 5, 2011Research and Development, Sales and Marketing AstraZeneca, research
AstraZeneca will make 22 of its compounds available free of charge to UK academia next year as part of a …
Actelion Pharmaceuticals Takes to the Cloud with Global Deployment of Veeva CRM and iRep
December 5, 2011BARCELONA, Spain – 1 December, 2011 – Before selecting cloud-based Veeva CRM for 500+ users worldwide, Actelion Ltd. had been …
Roche’s Lung cancer test approved for Europe
December 5, 2011Research and Development, Sales and Marketing Roche, Tarceva, lung cancer
A new test which should help to better target treatment of patients with non-small cell lung cancer (NSCLC) has received …
Astellas adds two senior executives at US site
December 5, 2011Business Services, Manufacturing and Production, Sales and Marketing Astellas
Astellas’ US subsidiary Agensys has appointed Frank Hudson as vice president of finance, and Wolfgang Noe as vice president of …
Stroke crisis to hit UK unless government acts, warns report
December 5, 2011Sales and Marketing BMS, Pfizer, Pradaxa, UK, stroke
Major improvements are needed in the treatment of atrial fibrillation to avoid a UK stroke epidemic, according to a new …
Teva gains tentative approval to sell generic Lipitor in 2012
December 5, 2011Sales and Marketing Lipitor, Pfizer, Ranbaxy, Teva
Teva has gained a tentative approval by the FDA to sell its generic form of Pfizer’s blockbuster statin Lipitor next …
UK unveils initiatives to support life sciences
December 5, 2011Research and Development, Sales and Marketing ABPI, UK, competitiveness, david cameron
The government has unveiled plans to help support the UK’s life science industries.The new package of measures includes £180 million …
Europe’s €80 billion will support research
December 2, 2011Research and Development, Sales and Marketing European Commission
The European Commission has created a new €80 billion budget in an effort to encourage research and innovation across the …
Boehringer will help develop Aveo’s lung cancer candidate
December 2, 2011Manufacturing and Production
Boehringer Ingelheim has agreed to help oncology specialist firm Aveo develop its lung cancer treatment ficlatuzumab. The agreement is for …
Merck KGaA appoints new heads of corporate auditing and strategy
December 2, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA
Merck KGaA has appointed Dr Friederike Rotsch as its new head of corporate auditing. She reports to Karl-Ludwig Kley, chairman …
Insight Research Group makes three senior appointments
December 2, 2011Business Services, Medical Communications, Sales and Marketing Insight research
Dave Bostock, Natasha Barretto and Jenny Service have all been appointed to senior positions within Insight. Bostock has been appointed …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
